E Fund Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44K | Sell |
11,357
-2,070
| -15% | -$8.01K | ﹤0.01% | 391 |
|
|
2025
Q1 | $67.1K | Buy |
13,427
+2,268
| +20% | +$11.3K | ﹤0.01% | 391 |
|
|
2024
Q4 | $80.5K | Buy |
11,159
+1,149
| +11% | +$8.28K | ﹤0.01% | 383 |
|
|
2024
Q3 | $61.5K | Sell |
10,010
-3,448
| -26% | -$21.2K | ﹤0.01% | 348 |
|
|
2024
Q2 | $89.5K | Sell |
13,458
-28,251
| -68% | -$188K | ﹤0.01% | 307 |
|
|
2024
Q1 | $425K | Buy |
+41,709
| New | +$425K | 0.03% | 193 |
|
|
2023
Q2 | – | Sell |
-29,334
| Closed | -$124K | – | 311 |
|
|
2023
Q1 | $124K | Sell |
29,334
-1,952
| -6% | -$8.25K | 0.01% | 317 |
|
|
2022
Q4 | $515K | Buy |
31,286
+10,646
| +52% | +$175K | 0.04% | 128 |
|
|
2022
Q3 | $264K | Buy |
+20,640
| New | +$264K | 0.02% | 255 |
|
|
2022
Q1 | – | Sell |
-11,936
| Closed | -$109K | – | 327 |
|
|
2021
Q4 | $109K | Buy |
+11,936
| New | +$109K | ﹤0.01% | 286 |
|